Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Cash from Investing Activities (2016 - 2024)

Historic Cash from Investing Activities for Creative Medical Technology Holdings (CELZ) over the last 7 years, with Q3 2024 value amounting to -$200000.0.

  • Creative Medical Technology Holdings' Cash from Investing Activities fell 10993.12% to -$200000.0 in Q3 2024 from the same period last year, while for Jun 2025 it was -$200000.0, marking a year-over-year decrease of 10211.24%. This contributed to the annual value of $6.3 million for FY2024, which is 8345.0% up from last year.
  • As of Q3 2024, Creative Medical Technology Holdings' Cash from Investing Activities stood at -$200000.0, which was down 10993.12% from $6.5 million recorded in Q1 2024.
  • Creative Medical Technology Holdings' Cash from Investing Activities' 5-year high stood at $6.5 million during Q1 2024, with a 5-year trough of -$5.1 million in Q4 2022.
  • Its 5-year average for Cash from Investing Activities is -$51203.7, with a median of -$200000.0 in 2021.
  • As far as peak fluctuations go, Creative Medical Technology Holdings' Cash from Investing Activities surged by 18000.0% in 2021, and later plummeted by 262865.5% in 2022.
  • Over the past 5 years, Creative Medical Technology Holdings' Cash from Investing Activities (Quarter) stood at -$250000.0 in 2020, then soared by 180.0% to $200000.0 in 2021, then tumbled by 2628.66% to -$5.1 million in 2022, then surged by 118.47% to $933914.0 in 2023, then plummeted by 121.42% to -$200000.0 in 2024.
  • Its last three reported values are -$200000.0 in Q3 2024, $6.5 million for Q1 2024, and $933914.0 during Q4 2023.